Volume 2(Supplement 1):46-49 Working together: establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri Lanka by P. Abeysinghe, L. Morawaka, S. Gunasekara, S. Suresh, P. H. S. P. Udara, P. P. R. Siriwardena, S. Milliken, D. D. F. Ma, and J. Moore BloodAdv Volume 2(Supplement 1):46-49 November 30, 2018 © 2018 by The American Society of Hematology
Map of Sri Lanka showing location of the NCI. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology
NCI team with Dr. Moore while in training at SVH. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology
The first patient at apheresis. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology
Staff discussing procedure with first patient. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology
Apheresis machine. Apheresis machine. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology
First patient after engraftment. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology
Cancer incidence data from Sri Lanka's National Cancer Control Programme. Cancer incidence data from Sri Lanka's National Cancer Control Programme. ASR, age-specific rate. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology
Disease percentage among patients at National Cancer Institute, Sri Lanka, during the first year. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology
Age groups of patients with autologous HSCT. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology
HSCT development timeline at NCI. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology